Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


16.07.2018

1 BMC Cancer
1 Cancer Lett
3 Int J Cancer
1 J Invest Dermatol
4 Melanoma Res
1 Oncogene
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. MCEVOY AC, Warburton L, Al-Ogaili Z, Celliers L, et al
    Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.
    BMC Cancer. 2018;18:726.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. LEE YS, Jung YY, Park MH, Yeo IJ, et al
    Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination.
    Cancer Lett. 2018;433:156-164.
    PubMed     Text format     Abstract available


    Int J Cancer

  3. IZRAELY S, Ben-Menachem S, Sagi-Assif O, Telerman A, et al
    The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31745.
    PubMed     Text format     Abstract available

  4. YANG CC, Chang CK, Chang MT, Shyur LF, et al
    Plant galactolipid dLGG suppresses lung metastasis of melanoma through deregulating TNF-alpha-mediated pulmonary vascular permeability and circulating oxylipin dynamics in mice.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31663.
    PubMed     Text format     Abstract available

  5. CERVENKA I, Mahamat-Saleh Y, Savoye I, Dartois L, et al
    Oral contraceptive use and cutaneous melanoma risk: A french prospective cohort study.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31644.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  6. TAKAISHI M, Sano S
    Transdifferentiation of melanoma cells by the reprogramming factors attenuates malignant nature in vitro and in vivo.
    J Invest Dermatol. 2018 Jul 7. pii: S0022-202X(18)32303.
    PubMed     Text format    


    Melanoma Res

  7. LAMIAUX M, Scalbert C, Lepesant P, Desmedt E, et al
    Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma.
    Melanoma Res. 2018 Jul 6. doi: 10.1097/CMR.0000000000000472.
    PubMed     Text format     Abstract available

  8. LYTH J
    Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.
    Melanoma Res. 2018 Jul 9. doi: 10.1097/CMR.0000000000000479.
    PubMed     Text format     Abstract available

  9. FERRIS LK, Gerami P, Skelsey MK, Peck G, et al
    Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.
    Melanoma Res. 2018 Jul 12. doi: 10.1097/CMR.0000000000000478.
    PubMed     Text format     Abstract available

  10. HUTCHINSON PE, Halsall JA, Popovici S, Papadogeorgakis E, et al
    Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity.
    Melanoma Res. 2018 Jul 12. doi: 10.1097/CMR.0000000000000475.
    PubMed     Text format     Abstract available


    Oncogene

  11. KUNZ M, Loffler-Wirth H, Dannemann M, Willscher E, et al
    RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas.
    Oncogene. 2018 Jul 11. pii: 10.1038/s41388-018-0385.
    PubMed     Text format     Abstract available


    PLoS One

  12. FLEMING NH, Grade MM, Bendavid E
    Impact of primary care provider density on detection and diagnosis of cutaneous melanoma.
    PLoS One. 2018;13:e0200097.
    PubMed     Text format     Abstract available

  13. UHRIG M, Simons D, Schlemmer HP
    Incidental pulmonary emboli in stage IV melanoma patients: Prevalence in CT staging examinations and improved detection with vessel reconstructions based on dual energy CT.
    PLoS One. 2018;13:e0199458.
    PubMed     Text format     Abstract available

  14. NAIR-SHALLIKER V, Egger S, Chrzanowska A, Mason R, et al
    Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels.
    PLoS One. 2018;13:e0193893.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: